Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Arocell Says FDA Informs That Review Of Arocells 510(k) Submission To Resume At Latest April 15

Feb 20 (Reuters) - AroCell AB (publ)  AROC.ST :
    * AROCELL - FDA INFORMS THAT REVIEW OF AROCELLS
510(K)SUBMISSION
WILL RESUME AT LATEST APRIL 15TH 2021

Source text for Eikon:  ID:nNDL7fG4Vx 
Further company coverage:  AROC.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on IDL Diagnostics AB (publ)

See all news